Nexlizet

Active Ingredient(s): Bempedoic Acid + Ezetimibe
FDA Approved: * February 26, 2020
Pharm Company: * ESPERION THERAPS INC
Category: Cholesterol

Bempedoic acid/ezetimibe, sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol.[1][3] It is a combination of bempedoic acid and ezetimibe.[1][2] The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation.[2] Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor and ezetimibe is a ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nexlizet Oral Tablet, Film Coated
NDC: 72426-818
Labeler:
Esperion Therapeutics, Inc.